Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) has shared an announcement.
Concord Healthcare Group Co., Ltd. announced the results of its 2025 Extraordinary General Meeting (EGM), where a special resolution was passed to abolish the Supervisory Committee. The audit committee of the Board will now assume the responsibilities of the Supervisory Committee. This decision reflects the company’s strategic move to streamline its governance structure, potentially impacting its operational efficiency and stakeholder relations positively.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$2.00 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the healthcare sector. It is listed on the Hong Kong Stock Exchange and engages in providing healthcare services, focusing on enhancing its corporate governance structures.
Average Trading Volume: 1,475,137
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.52B
See more data about 2453 stock on TipRanks’ Stock Analysis page.

